Floatz logo

Sodium Thiosulfate

Central Nervous System Lymphoma

OHSU Knight Cancer InstituteSmall moleculePhase 1/2Dormant
CC
45/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
81/ 100

Competitive context

74 Active assets in the Central Nervous System Lymphoma cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 4BBB
(+)-VINCRISTINE
Ono Pharmaceutical Co., Ltd.
Phase 4BBB
METHOTREXATE
Assistance Publique Hopitaux De Marseille
Phase 4BB
Inno-206
Juan P. Alderuccio, MD
Phase 4BB
Orelabrutinib
The First Affiliated Hospital with Nanjing Medical University
Phase 3BB

View all 50 →

Same molecule, other indications

Sodium Thiosulfate is also rated in:

central nervous system neoplasmDormant
BB
Indicative ·
70 / 100
View asset →
sarcomaDormant
BB
Indicative ·
65 / 100
View asset →
Epithelial Ovarian CancerDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →